Related Experiment Video
Updated: Mar 26, 2026

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
Published on: October 27, 2023
Probiotics as Antifungals in Mucosal Candidiasis
Victor H Matsubara1, H M H N Bandara2, Marcia P A Mayer3
1School of Dentistry, University of Queensland, Brisbane, Australia Department of Microbiology, Institute of Biomedical Sciences Department of Prosthodontics, School of Dentistry, University of São Paulo, Brazil.
Probiotics, especially lactobacilli, show promise in managing Candida infections by suppressing fungal growth and colonization. Clinical trials suggest benefits in reducing oral, vaginal, and enteric Candida, potentially aiding in preventing invasive fungal infections.
Area of Science:
- Mycology
- Microbiology
- Immunology
Background:
- Candida is an opportunistic pathogen causing mucosal and systemic infections.
- Antifungal drug resistance and side effects limit current treatments.
- Probiotics are explored as an alternative for candidiasis management.
Purpose of the Study:
- To analyze the efficacy of probiotics in controlling Candida colonization.
- To review evidence for probiotics in preventing and treating candidiasis.
Main Methods:
- In vitro studies assessing probiotic effects on Candida growth and biofilm.
- Clinical trials evaluating probiotic impact on Candida colonization and infection incidence.
Main Results:
- Probiotics, particularly lactobacilli, inhibit Candida growth and biofilm formation in vitro.
- Clinical trials demonstrate probiotic effectiveness in reducing oral, vaginal, and enteric Candida colonization.
- Probiotics may decrease the incidence of invasive fungal infections in critically ill patients.
Conclusions:
- Probiotics are a viable alternative for managing candidiasis.
- Lactobacilli show significant potential in combating Candida infections.
- Further research may establish probiotics as a key strategy against chronic mucosal candidiasis.
Related Concept Videos
Antifungal Agents
Probiotics
Fungal Group Zygomycota
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Fungal Phylum Microsporidia
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

